Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001417952-26-000002

Chief Executive Officer acquired 1,106 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Grant or award : show line 1 in the form +1,106 $2.71 $2,997 1,060,087 D
Loading xslF345X06/wk-form4_1783545408.xml…